Call Us Now at 888-787-2990
Dr. Jesus Perez speaks about Stem Cell therapy at The Regenerative Medicine Institute.
Chronic obstructive pulmonary disease (COPD), refers to chronic bronchitis and emphysema, a pair of commonly co-existing diseases of the lungs in which the airways become narrowed. This leads to a limitation of the flow of air to and from the lungs causing shortness of breath. In clinical practice, COPD is defined by its characteristically low airflow on lung function tests. In contrast to asthma, this limitation is poorly reversible and usually gets progressively worse over time.
COPD is caused by noxious particles or gas, most commonly from tobacco smoking, which triggers an abnormal inflammatory response in the lung. The inflammatory response in the larger airways is known as chronic bronchitis, which is diagnosed clinically when people regularly cough up sputum. In the alveoli, the inflammatory response causes destruction of the tissues of the lung, a process known asemphysema. The natural course of COPD is characterized by occasional sudden worsenings of symptoms called acute exacerbations, most of which are caused by infections or air pollution.
The diagnosis of COPD requires lung function tests. Important management strategies are smoking cessation, vaccinations, rehabilitation, and drug therapy (often using inhalers). Some patients go on to require long-term oxygen therapy or lung transplantation.
Worldwide, COPD ranked as the sixth leading cause of death in 1990. It is projected to be the fourth leading cause of death worldwide by 2030 due to an increase in smoking rates and demographic changes in many countries. COPD is the fourth leading cause of death in the U.S. and the economic burden of COPD in the U.S. in 2007 was $42.6 billion in health care costs and lost productivity.
Clinical trials on the impact of stem cells therapies on Chronic Obstructive Pulmonary Disease have begun. And while studies are in progress, there has been a plethora of anecdotal evidence that stem cell therapy will revolutionize how COPD patients are treated in the future. (See above testimonial)
Adult Stem Cell therapy is an exciting break through therapeutic approach to managing health. Physicians world-wide acknowledge that stem cell therapies will revolutionize medicine in the coming years. However, Stem Cell therapy is considered a controversial treatment in some medical and regulatory circles, as the research and clinical trials are still in their infancy. As a result Regenerative Medicine Institute can and does not make any specific claims to the medical efficacy or safety of stem cell therapies that are offered.
All potential patients should consult with their own physician about stem cell therapy. The Regenerative Medicine Institute screens all patients and only accepts those that it feels would benefit from Stem Cell treatments. However, each patient is unique and no results can be guaranteed.
The Regenerative Medicine Institute will provide continuing updates, information on current research on stem cell therapeutics and research, helping patients and their consulting physicians make their own informed decisions on whether or not to pursue treatment.
(The above testimonial represents only this patient's experience. It does not imply that any other patient may expect or receive similar results.)